<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="90608">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01731353</url>
  </required_header>
  <id_info>
    <org_study_id>Fungi001</org_study_id>
    <nct_id>NCT01731353</nct_id>
  </id_info>
  <brief_title>Fungiscope - A Global Emerging Fungal Infection Registry</brief_title>
  <acronym>Fungiscope</acronym>
  <official_title>Fungiscope - A Global Emerging Fungal Infection Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cologne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Astellas Pharma GmbH</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Gilead Sciences</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Cologne</source>
  <oversight_info>
    <authority>Germany: German Institute of Medical Documentation and Information</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this registry is to broaden the knowledge on epidemiology, diagnostic
      procedures and clinical course of emerging invasive fungal infections.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The specific objectives are:

        1. To determine the fungal species causing invasive fungal infection in different parts of
           the world.

        2. To determine the clinical pattern of disease and document procedures performed for
           confirmation of the diagnosis.

        3. To describe the therapeutic regimens used and their efficacy.

        4. To share clinical isolates among the contributors of Fungiscope.

        5. To develop molecular biology tools for identification of strains in histopathologically
           proven invasive fungal infection.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2003</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Treatment efficacy of emerging fungal infections (failure, stable disease, partial response or complete response)</measure>
    <time_frame>At 90 days from diagnosis</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Invasive Fungal Infection</condition>
  <arm_group>
    <arm_group_label>Emerging fungal infections</arm_group_label>
    <description>Web-based registry of invasive infections by emerging fungi</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      -  fixed tissue

        -  fungal culture
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Invasive infections caused by emerging fungi
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cultural, histopathological, antigen, or DNA evidence of invasive fungal infection

        Exclusion Criteria:

          -  Infection due to Aspergillus spp., Candida spp., Cryptococcus neoformans,
             Pneumocystis jiroveci

          -  Endemic fungal infection such as coccidioidomycosis or histoplasmosis

          -  Colonisation or other non-invasive infection
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Oliver A. Cornely, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of Cologne</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Oliver A Cornely, Prof.</last_name>
    <phone>+49 221 478</phone>
    <phone_ext>6494</phone_ext>
    <email>oliver.cornely@ctuc.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Cologne</name>
      <address>
        <city>Cologne</city>
        <state>NRW</state>
        <zip>50924</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oliver A Cornely, Prof.</last_name>
      <phone>+49 221 478</phone>
      <phone_ext>6494</phone_ext>
      <email>oliver.cornely@ctuc.de</email>
    </contact>
    <investigator>
      <last_name>Maria J Vehreschild, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kerstin Wahlers, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Janne Vehreschild, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.fungiscope.net</url>
    <description>Fungiscope - A Global Emerging Fungal Infection Registry</description>
  </link>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 19, 2013</lastchanged_date>
  <firstreceived_date>November 15, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Cologne</investigator_affiliation>
    <investigator_full_name>Oliver Cornely, MD</investigator_full_name>
    <investigator_title>Dr. med.</investigator_title>
  </responsible_party>
  <keyword>invasive fungal infection</keyword>
  <keyword>Web-based registry</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Mycoses</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
